Related Experiment Video
Updated: Jan 19, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Extracellular ADP augments microglial inflammasome and NF-κB activation via the P2Y12 receptor
Tomonori Suzuki1,2, Kuniko Kohyama1, Kengo Moriyama1
1Developmental Neuroimmunology Project, Department of Brain Development and Neural Regeneration, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Abstract:
The NLRP3 inflammasome is a molecular complex that translates signals from pathogens and tissue damage into inflammatory responses, and plays crucial roles in numerous neurological diseases. Activation of the NLRP3 inflammasome leads to caspase-1 dependent cleavage of pro-IL-1β to form mature IL-1β. By acting on the P2X7 purinergic receptor, extracellular ATP is one of the major stimuli that activates the NLRP3 inflammasome. Although microglia express multiple purinergic receptors, their roles in inflammasome-mediated inflammation are largely unknown. We studied the role of the P2Y12 receptor, a metabotropic P2Y receptor enriched in microglia, on inflammation in vitro. Inhibition of the microglial P2Y12 receptor by PSB0739 or siRNA knockdown suppressed IL-1β release. P2Y12 receptor-deficient microglia displayed markedly attenuated IL-1β mRNA expression and release. P2Y12 receptor blockade also suppressed IL-6 production. Both IL-1β and IL-6 responses were augmented by extracellular ADP or ADP-βS and were abrogated by PSB0739. Mechanistically, ADP-βS potentiated NF-κB activation. In addition, ADP altered mitochondrial membrane potential in combination with ATP and increased the number of caspase-1 positive cells through the P2Y12 receptor. These results elucidate a novel inflammatory mechanism by which extracellular ADP acts on the P2Y12 receptor to activate NF-κB and the NLRP3 inflammasome to enhance microglial inflammation.
Insights
Extracellular ADP activates the P2Y12 receptor on microglia, enhancing NLRP3 inflammasome activation and subsequent release of inflammatory cytokines like IL-1β and IL-6, contributing to neurological inflammation.
Area of Science:
- Neuroimmunology
- Molecular Biology
- Inflammation Research
Background:
- The NLRP3 inflammasome is a key mediator of inflammatory responses in neurological diseases.
- Extracellular ATP activates NLRP3 inflammasome via the P2X7 receptor, but roles of other purinergic receptors in microglia remain unclear.
- Microglia, the brain's immune cells, express various purinergic receptors, including the P2Y12 receptor.
Purpose of the Study:
- To investigate the role of the microglial P2Y12 receptor in inflammasome-mediated inflammation.
- To elucidate the signaling pathways involved in P2Y12 receptor-mediated microglial activation.
Main Methods:
- In vitro studies using microglia.
- Inhibition of P2Y12 receptor using PSB0739 and siRNA knockdown.
- Measurement of IL-1β and IL-6 release and mRNA expression.
- Assessment of NF-κB activation, mitochondrial membrane potential, and caspase-1 activation.
Main Results:
- P2Y12 receptor inhibition or deficiency significantly suppressed IL-1β and IL-6 release from microglia.
- Extracellular ADP and ADP-βS augmented IL-1β and IL-6 production, effects blocked by P2Y12 inhibition.
- ADP-βS potentiated NF-κB activation, and ADP altered mitochondrial membrane potential and increased caspase-1 positive cells via P2Y12.
Conclusions:
- Extracellular ADP acts through the P2Y12 receptor to enhance microglial inflammation.
- This mechanism involves NF-κB activation and potentiation of the NLRP3 inflammasome pathway.
- The P2Y12 receptor represents a novel target for modulating neuroinflammation.
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Intracellular Signaling Affects Focal Adhesions
Some...
IP3/DAG Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Intracellular Signaling Cascades
Amplifying Signals via Second Messengers

